Evolus Inc
Evolus Inc (EOLS) Option Chain
Read more
Tracking the EOLS option chain helps you see every strike and expiry on Evolus Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of EOLS options activity at a glance. Use our scanner to monitor the EOLS option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For EOLS stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where EOLS options are being actively traded, and where they are not.
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 0.00 | 0 | 0 | 0.08 | 4.19 | 2.05 | 6.50 | 2.50 | -62.63 | — | 1.75 | 0.00 | 1.75 | 0 | 0 | 100.00 |
| 0.03 | 7 | 0 | 0.01 | 1.69 | 0.20 | 3.20 | 5.00 | -25.26 | — | 1.50 | 0.00 | 1.50 | 0 | 4 | 99.97 |
| 92.09 | 35 | 0 | 1.35 | 0.00 | — | 1.35 | 7.50 | +12.11 | — | 1.85 | 0.81 | 1.04 | 0 | 42 | 7.91 |
| 100.00 | 5,025 | 0 | 0.05 | 0.00 | — | 0.05 | 10.00 | +49.48 | 1.55 | 5.60 | 3.31 | 0.27 | 0 | 0 | 0.00 |
| 100.00 | 0 | 0 | 1.50 | 0.00 | — | 1.50 | 12.50 | +86.85 | 3.50 | 8.40 | 5.81 | 0.14 | 0 | 0 | 0.00 |
As of Nov 17, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryDrug Manufacturers - Specialty & Generic
- SectorHealthcare
- IV Rank44.05% Moderate
- Market cap (M$)443
- 52 weeks high-28.14%
- 52 weeks low73.32%
- Analyst recommendationStrong Buy
1.33 - Target price$15.40
130.19% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-04
- P/E—
- Future P/E20.27
- EPS (ttm)-0.47
- EPS growth next 5 years—
As of Nov 17, 2026